Literature DB >> 2975499

Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.

D Gilson1, D Ash, I Driver, J W Feather, S Brown.   

Abstract

Six patients with a total of 34 assessible subcutaneous or cutaneous lesions were treated with photodynamic therapy using 1.0, 1.5 or 2.0 mg kg-1 of photofrin II and 25-100 J cm-2 of red light (630 nm). The incidence of complete tumour response and skin necrosis were used to try to assess the therapeutic ratio of photodynamic therapy. The tumour response rate was 47%. The rate of tumour control and necrosis increased in parallel with dose of photosensitizer and light used, implying a low therapeutic ratio. However, the use of necrosis with eschar formation as an end-point for severe normal tissue damage is questioned as the skin healed completely in all cases and with minimal discomfort to the patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975499      PMCID: PMC2246824          DOI: 10.1038/bjc.1988.282

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

2.  Photoradiation in the treatment of recurrent breast carcinoma.

Authors:  T J Dougherty; G Lawrence; J H Kaufman; D Boyle; K R Weishaupt; A Goldfarb
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

3.  Transmittance of nonionizing radiation in human tissues.

Authors:  S Wan; J A Parrish; R R Anderson; M Madden
Journal:  Photochem Photobiol       Date:  1981-12       Impact factor: 3.421

4.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

Authors:  C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

5.  Photoradiation therapy for the treatment of malignant tumors.

Authors:  T J Dougherty; J E Kaufman; A Goldfarb; K R Weishaupt; D Boyle; A Mittleman
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

6.  Preliminary report of a pilot study of photoradiation therapy for the treatment of superficial malignancies of the skin, head and neck.

Authors:  J A Carruth; A L McKenzie
Journal:  Eur J Surg Oncol       Date:  1985-03       Impact factor: 4.424

7.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers.

Authors:  W M Star; H P Marijnissen; A E van den Berg-Blok; J A Versteeg; K A Franken; H S Reinhold
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

8.  Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

Authors:  H Barr; C J Tralau; A J MacRobert; N Krasner; P B Boulos; C G Clark; S G Bown
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

  8 in total
  5 in total

1.  Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue.

Authors:  H Barr; P Chatlani; C J Tralau; A J MacRobert; P B Boulos; S G Bown
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

Review 2.  Photodynamic therapy--achievements and prospects.

Authors:  D Ash; S B Brown
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

Review 3.  BODIPYs in PDT: A Journey through the Most Interesting Molecules Produced in the Last 10 Years.

Authors:  Miryam Chiara Malacarne; Marzia Bruna Gariboldi; Enrico Caruso
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

4.  Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours.

Authors:  C P Lowdell; D V Ash; I Driver; S B Brown
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

5.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.

Authors:  F Cairnduff; M R Stringer; E J Hudson; D V Ash; S B Brown
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.